<p> Reproductive Medicine Module 1: Female Reproductive Endocrinology Number  = Not required Observed Direct supervision Independent practice</p><p>Anatomy and physiology</p><p>Neuroendocrine anatomy and physiology</p><p>Screening</p><p>Pituitary MRI/CT </p><p>Pelvic MRI/CT</p><p>Abdominal CT</p><p>Hypothalamic / Pituitary dysfunction</p><p>Hypogonadatrophic hypogonadism </p><p>Hypothalamic Disorders </p><p>Anorexia Nervosa/exercise and lifestyle- related disorders</p><p>Pituitary adenoma</p><p>Kallman Syndrome</p><p>Hyperprolactinaemia</p><p>Experience Last updated 20 July 2007 Reproductive Medicine Module 1: Female Reproductive Endocrinology Number  = Not required Observed Direct supervision Independent practice</p><p>Adrenal Dysfunction</p><p>Cushing Syndrome</p><p>Nelson Syndrome</p><p>Addison Disease</p><p>Adrenal Hyperplasia</p><p>Thyroid Disorders</p><p>Hypothyroidism</p><p>Hyperthyroidism</p><p>Other</p><p>Diabetes Mellitus</p><p>Experience Last updated 20 July 2007 1b: The ovary and polycystic ovary syndrome Number  = Not required Observed Direct supervision Independent practice Ovary and polycystic ovary syndrome (PCOS)</p><p>Ovarian anatomy physiology</p><p>Diagnosis of PCOS</p><p>Ultrasound imaging of polycstic ovaries</p><p>Management of obesity</p><p>Dietary advice</p><p>Management of anovulation/oligo-ovulation</p><p>Ovulation induction in PCOS</p><p>Antioestrogens</p><p>Metformin/insulin sensitisers</p><p>Gonadotropin therapy</p><p>Ovarian diathermy</p><p>Aromatase inhibitors</p><p>Management of hyperandrogenism (hirsutism / acne / alopecia)</p><p>Experience Last updated 20 July 2007 1c: Paediatric and adolescent gynaecology Number  = Not required Observed Direct supervision Independent practice</p><p>Screening and diagnosis</p><p>Pelvic / abdominal MRI/CT</p><p>Developmental Disorders</p><p>Normal growth and development/ambiguous genitalia/genital anomalies</p><p>Intersex disorders/Turner syndrome</p><p>Endocrine disturbance</p><p>Precocious puberty</p><p>Delayed puberty</p><p>Late-onset adrenal hyperplasia</p><p>Primary amenorrhoea</p><p>Management of survivors of childhood cancer</p><p>Experience Last updated 20 July 2007 Gynaecological endocrine clinic attendance</p><p>Clinic Date attended Comments</p><p>Experience Last updated 20 July 2007 1d: Contraception and termination of pregnancy Number  = Not required Observed Direct supervision Independent practice</p><p>Contraceptive Counselling</p><p>Combined oral contraceptive pill</p><p>Progesterone-only pill</p><p>Depot</p><p>Implants</p><p>Intrauterine contraceptive devices (including Cu and Levonorgestrel based systems)</p><p>Termination Provision</p><p>First trimester termination</p><p>Mid trimester termination</p><p>Late termination</p><p>Selective fetal reduction</p><p>Experience Last updated 20 July 2007 Family planning clinic attendance</p><p>Clinic Date attended Comments</p><p>Experience Last updated 20 July 2007 1e: Menopause and premature ovarian failure Number  = Not required Observed Direct supervision Independent practice</p><p>Management of Menopause</p><p>Menopause clinic attendance</p><p>Choice or hormone replacement therapy (HRT)</p><p>Adverse effects and risks of HRT</p><p>Management of premature ovarian failure</p><p>Endocrine assessment</p><p>Fertility management</p><p>Immunological investigation</p><p>Counselling</p><p>HRT therapy</p><p>Dual energy X-ray absorptiometry bone scanning</p><p>Experience Last updated 20 July 2007 Premature ovarian failure clinc attendance</p><p>Clinic Date attended Comments</p><p>Experience Last updated 20 July 2007 Menopause clinic attendance</p><p>Clinic Date attended Comments</p><p>Experience Last updated 20 July 2007</p>